US Stock MarketDetailed Quotes

MRNS Marinus Pharmaceuticals

Watchlist
  • 1.260
  • +0.040+3.28%
Close Aug 16 16:00 ET
  • 1.260
  • 0.0000.00%
Post 20:01 ET
69.41MMarket Cap-473P/E (TTM)

Marinus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Marinus Pharmaceuticals Q2 2024 Earnings Date

Currency：USDAug 13, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
9.51M
8.06M
-1.45M
Miss Est.
+56.34%
+32.48%
-15.26%
EPS
-0.59
-0.63
-0.04
Miss Est.
+2.62%
-3.28%
-6.08%
Analyst Rating
Buy

Aug 17, 2024

Marinus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 11.439M--
--2024/Q3-- / 9.419M--
Aug 13, 20242024/Q28.056M / 9.507M--
May 8, 20242024/Q17.679M / 9.089M--
Mar 5, 20242023/Q47.190M / 8.139M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 11.439M--
--2024/Q3-- / 9.419M--
Aug 13, 20242024/Q28.056M / 9.507M--
May 8, 20242024/Q17.679M / 9.089M--
Mar 5, 20242023/Q47.190M / 8.139M--

Unlock Free Earnings Estimates

Marinus Pharmaceuticals Earnings Reports

  • Marinus Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 13 08:02 ET

  • Marinus Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 8 07:13 ET

  • Marinus Pharmaceuticals | 10-K: FY2023 Annual Report

    Mar 5 16:19 ET

  • Marinus Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 7, 2023 07:31 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 17, 2024

    Buy

    • Buy

      55.56%

    • Hold

      44.44%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg